Esomeprazole Magnesium, NEXIUM 10 mg gastro-resistant granules for oral suspension, sachet, Esomeprazole Magnesium
D9612C09998
Phase 3 small_molecule active
Quick answer
Esomeprazole Magnesium, NEXIUM 10 mg gastro-resistant granules for oral suspension, sachet, Esomeprazole Magnesium for Erosive Esophagitis is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Erosive Esophagitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active